Kathy Hamon
Family Medicine · Roanoke, VANPI 1154312452
Payments from drug & device makers
Across 101 payments — averaging $19.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$342
- Abbott$274
- Novo Nordisk$191
- GSK$158
- AstraZeneca$149
- Lilly USA, LLC$117
- plus $742 from 24 others
What the payments were for
- Food & beverage$1,972100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 19 | $342 |
| Abbott | 13 | $274 |
| Novo Nordisk | 10 | $191 |
| GSK | 8 | $158 |
| AstraZeneca(2 entities) | 9 | $149 |
| Lilly USA, LLC | 6 | $117 |
| Mylan Specialty L.p. | 4 | $96 |
| Insulet Corporation | 3 | $66 |
| Johnson & Johnson | 2 | $62 |
| Novartis | 3 | $61 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $45 |
| Tandem Diabetes Care, Inc. | 2 | $33 |
| Averitas Pharma Inc. | 2 | $33 |
| Nestle Healthcare Nutrition Inc. | 1 | $32 |
| Dexcom, Inc. | 2 | $30 |
| Indivior Inc. | 1 | $25 |
| Pfizer | 1 | $25 |
| Recor Medical Inc | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $21 |
| Amgen | 1 | $19 |
| Rhythm Pharmaceuticals, Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Corcept Therapeutics | 1 | $17 |
| Verona Pharma, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| Eisai Inc. | 1 | $13 |
How this compares
$1,972 in reported general payments places this provider in the 75th percentile of 2,553 family medicine providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 112 | $119,771 |
| MounjaroTirzepatide | 56 | $59,979 |
| EliquisApixaban | 47 | $41,669 |
| JardianceEmpagliflozin | 28 | $27,528 |
| TrulicityDulaglutide | 20 | $25,779 |
| LinzessLinaclotide | 32 | $16,238 |
| JanuviaSitagliptin Phosphate | 18 | $15,416 |
| MyrbetriqMirabegron | 29 | $14,770 |
| XareltoRivaroxaban | 14 | $12,395 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $9,671 |
| SymbicortBudesonide/Formoterol Fumarate | 22 | $7,773 |
| JentaduetoLinagliptin/Metformin Hcl | 12 | $7,063 |
| VeozahFezolinetant | 11 | $5,950 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 31 | $5,541 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 12 | $4,696 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $191 | $119,771112 claims |
| Lilly USA, LLCMounjaro, Trulicity | $117 | $85,75876 claims |
| PfizerEliquis | $25 | $41,66947 claims |
| Boehringer IngelheimJardiance, Jentadueto | $17 | $34,59140 claims |
| Astellas Pharma US IncMyrbetriq, Veozah | $21 | $20,72040 claims |
| AbbVieLinzess, Synthroid | $342 | $18,88169 claims |
| Johnson & JohnsonXarelto | $62 | $12,39514 claims |
| GSKTrelegy Ellipta | $158 | $9,67111 claims |
| AstraZenecaSymbicort | $149 | $7,77322 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,553 family medicine providers in Virginia.
Other family medicine in Roanoke
- Aaron HartmanMidlothian$17.4M
- John ScottGlen Allen$16.7M
- Banu MyneniPortsmouth$12.8M
- Patricia HouserWinchester$3.5M
- Stephan JannachDanville$3M
- Linda SchneiderHampton$2.1M
- Jennifer BrownMidlothian$1.3M
- Brian McCormickHampton$793K
- Jerome DanielNorth Chesterfield$779K
- Samir AbdelshaheedChesapeake$642K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.